Global Gastric Ulcers Market Projected to Expand at 5.2% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Gastric Ulcers Market Expected To Become By 2029 Compared With Its 2025 Level?

The gastric ulcers market size has experienced significant growth in recent years. It is projected to expand from $4.29 billion in 2024 to $4.53 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. The market’s past expansion can be ascribed to the increasing prevalence of helicobacter pylori infections, a greater utilization of nonsteroidal anti-inflammatory drugs (NSAIDs), the global rise in the geriatric population, enhanced awareness initiatives for gastric ulcer prevention, and an uptick in stress-related disorders.

The gastric ulcers market is poised for robust expansion over the coming years. It is projected to reach $5.55 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.2%. This anticipated growth during the forecast period is driven by several factors, such as enhanced diagnostic methods, the prevalence of unhealthy eating patterns, progress in therapeutic alternatives like proton pump inhibitors (PPIs), an increasingly older demographic leading to a greater disease load, and the development of healthcare facilities in developing economies. Key developments expected within this period encompass a move towards combination therapies for improved effectiveness, an increasing inclination for less invasive treatment methods, the incorporation of digital health tools in managing the condition, a heightened demand for over-the-counter (OTC) medications for ulcers, and the broader application of personalized medicine strategies in ulcer care.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Drivers Are Shaping The Gastric Ulcers Industry’s Market Share?

The expanding older adult demographic is projected to boost the expansion of the gastric ulcers market in the foreseeable future. This demographic typically includes individuals 65 years and above, who have particular health needs associated with aging. The rise in this age group stems from healthcare improvements extending life expectancy and reduced birth rates across numerous global regions. Gastric ulcers frequently affect the geriatric population because of greater NSAID usage and diminished mucosal defense, often resulting in elevated complication risks. For example, in January 2024, data from the Population Reference Bureau (PRB), a US-based private non-profit, indicates that the number of Americans aged 65 and older is predicted to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Furthermore, this group’s share of the total population is expected to increase from 17% to 23%. This evolution signifies a considerable aging pattern within the U.S. population, with these forecasts emphasizing the growing necessity to cater to the requirements of older individuals in diverse fields. Consequently, the increasing geriatric population is propelling the growth of the gastric ulcers market.

Which Key Segments Fueling The Gastric Ulcers Market?

The gastric ulcersmarket covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes

2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole

2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine

3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate

4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline

5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies

Which Ongoing Trends Are Expected To Shape The Gastric Ulcers Market Outlook?

Leading companies in the gastric ulcer market are concentrating on developing innovative products, including new drug formulations, to improve treatment effectiveness and minimize side effects. New formulation drugs are defined as medicines created with novel combinations of active ingredients, delivery systems, or dosage forms to enhance their efficacy, safety, and patient compliance. For example, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, introduced Rabeprazole + Levosulpiride SR Capsules, designed to offer superior relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively addressing gastrointestinal disorders like gastroesophageal reflux disease (GERD) and gastric ulcers. This particular formulation not only diminishes gastric acid secretion but also boosts gastric motility, delivering comprehensive relief from symptoms such as heartburn and indigestion.

Which Key Players Are Driving Competition In The Gastric Ulcers Market?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

What Are The Key Regional Factors Influencing The Gastric Ulcers Market Growth?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastric Ulcers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795